Cargando…

Separated at Birth: The Politics of Pharmacare for All in Canada and Medicare for All in the United States Comment on "Universal Pharmacare in Canada"

Policy decisions about healthcare coverage in Canada and the United States in the 1960s placed two virtually identical systems on different evolutionary paths in the physician and hospital sectors. However, prescription drug coverage remained outside Canada’s single-payer model, and employer-based c...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tuohy, Carolyn Hughes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kerman University of Medical Sciences 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947896/ https://www.ncbi.nlm.nih.gov/pubmed/32610786 http://dx.doi.org/10.34172/ijhpm.2020.31

Ejemplares similares

Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"
por: Gagnon, Marc-André
Publicado: (2020)

The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada"
por: Acri née Lybecker, Kristina M. L.
Publicado: (2020)

National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"
por: Rawson, Nigel S. B.
Publicado: (2020)

It’s Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada"
por: Lexchin, Joel
Publicado: (2020)

Universal Pharmacare in Canada: A Prescription for Equity in Healthcare
por: Hajizadeh, Mohammad, et al.
Publicado: (2019)

It Won’t Be Easy: How to Make Universal Pharmacare Work in Canada
por: Lewis, Steven
Publicado: (2019)

Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare
por: Brandt, Jaden, et al.
Publicado: (2018)

Public–private partnership alternative for a national pharmacare program in Canada
por: Nauenberg, Eric, et al.
Publicado: (2023)

After More Than 50 Years, Pharmacare (and Dental Care) are Coming to Canada
por: Lexchin, Joel
Publicado: (2022)

Interprovincial Differences in Access to Phosphate Lowering Medication; Implications for Care as Canada Moves Toward a National Pharmacare Program
por: Wilson, Tristin E., et al.
Publicado: (2023)

Universal Pharmacare – Redressing Social Inequities in the Canadian Health System: A Response to Recent Commentaries
por: Hajizadeh, Mohammad, et al.
Publicado: (2020)

The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiaries of the Seniors' Pharmacare Program in Nova Scotia, Canada
por: Sanyal, Chiranjeev, et al.
Publicado: (2008)

Introduction of publicly funded pharmacare and socioeconomic disparities in glycemic management in children and youth with type 1 diabetes in Ontario, Canada: a population-based trend analysis
por: Giruparajah, Mohana, et al.
Publicado: (2022)

The impact of OHIP+ pharmacare on use and costs of public drug plans among children and youth in Ontario: a time-series analysis
por: Miregwa, Benard N., et al.
Publicado: (2022)

The impact of prescription opioids on all-cause mortality in Canada
por: Imtiaz, Sameer, et al.
Publicado: (2016)

Impact of a publicly-funded pharmacare program policy on benzodiazepine dispensing among children and youth: a population-based natural experiment
por: Antoniou, Tony, et al.
Publicado: (2023)

Impact of a Publicly-Funded Pharmacare Program on Prescription Stimulant use Among Children and Youth: A Population-Based Observational Natural Experiment
por: Antoniou, Tony, et al.
Publicado: (2023)

Current Breast Milk PFAS Levels in the United States and Canada: After All This Time, Why Don’t We Know More?
por: LaKind, Judy S., et al.
Publicado: (2022)

Keeping the front door open: ensuring access to primary care for all in Canada
por: Kiran, Tara
Publicado: (2022)

Rethinking the politics and implementation of health in all policies
por: Wismar, Matthias, et al.
Publicado: (2013)

Public Spending on Health Services and Policy Research in Canada: A Reflection on Thakkar and Sullivan: Comment on "Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal"
por: Adams, Owen
Publicado: (2017)

Making Research Matter: Comment on "Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal"
por: Hunter, David J., et al.
Publicado: (2017)

Social, political, commercial, and corporate determinants of rural health equity in Canada: an integrated framework
por: Leimbigler, Betsy, et al.
Publicado: (2022)

The state of tuberculosis surveillance in Canada
por: Campbell, Jonathon R., et al.
Publicado: (2023)

The Challenges of Projecting the Public Health Impacts of Marijuana Legalization in Canada : Comment on "Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts"
por: Lake, Stephanie, et al.
Publicado: (2016)

When Coproduction Is Unproductive: Comment on "Experience of Health Leadership in Partnering with University-Based Researchers in Canada: A Call to ‘Re-Imagine’ Research"
por: Kreindler, Sara A.
Publicado: (2019)

Overview of the Drivers of Low-Value Care: Comment on "Key Factors that Promote Low-Value Care: Views of Experts From the United States, Canada, and the Netherlands"
por: Zadro, Joshua R., et al.
Publicado: (2022)

Health Services Research Spending and Healthcare System Impact: Comment on "Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal"
por: Barer, Morris L., et al.
Publicado: (2017)

Why Canada Is in Court to Protect Healthcare for All: Global Implications for Universal Health Coverage
por: Frank, John, et al.
Publicado: (2021)

Reimagining Researchers in Health Research Comment on "Experience of Health Leadership in Partnering With University-Based Researchers in Canada: A Call to ‘Re-Imagine’ Research"
por: Plamondon, Katrina M.
Publicado: (2020)

The Devil Is in the Details! On Regulating Cannabis Use in Canada Based on Public Health Criteria: Comment on "Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts"
por: Rehm, Jürgen, et al.
Publicado: (2016)

Low-Value Care: Convergence and Challenges : Comment on "Key Factors That Promote Low-Value Care: Views From Experts From the United States, Canada, and the Netherlands"
por: Ingvarsson, Sara, et al.
Publicado: (2022)

Using a Stages Model to Reveal the Politics in the Health Policy Process: Comment on "Modelling the Health Policy Process: One Size Fits All or Horses for Courses?"
por: Sheaff, Rod
Publicado: (2023)

What's Canadian about Medicare? A Comparative Perspective on Health Policy
por: Tuohy, Carolyn Hughes
Publicado: (2018)

Physician Fee Levels: Medicare Versus Canada
por: Welch, W. Pete, et al.
Publicado: (1993)

Overcoming Political Fragmentation: The Potential of Meso-Level Mechanisms: Comment on "Integration or Fragmentation of Health Care? Examining Policies and Politics in a Belgian Case Study"
por: Gray, Carolyn Steele
Publicado: (2022)

Advancing Health Services Collaborative and Partnership Research Comment on "Experience of Health Leadership in Partnering with University-Based Researchers in Canada – A Call to ‘Re-imagine’ Research"
por: Nyström, Monica E., et al.
Publicado: (2020)

Context, Culture, and the Complexity of De-Implementing Low-Value Care: Comment on "Key Factors that Promote Low-Value Care: Views of Experts From the United States, Canada, and the Netherlands"
por: Sypes, Emma E., et al.
Publicado: (2022)

Models of professional regulation: institutionalizing an agency relationship
por: Tuohy, Carolyn Hughes
Publicado: (2013)

Tuberculosis and COVID-19 in Canada
por: Long, Richard, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1v7dhkplliibqktf7oana1hhhe